Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes

BACKGROUND/AIMS: To assess visual acuity (VA) outcomes and antivascular endothelial growth factor (anti-VEGF) therapy intensity in retinal vein occlusion (RVO)-related macular oedema (ME). METHODS: A retrospective study was completed in treatment-naïve patients with RVO-related ME from 2013 to 2019,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciulla, Thomas, Pollack, John S, Williams, David F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639936/
https://www.ncbi.nlm.nih.gov/pubmed/33055088
http://dx.doi.org/10.1136/bjophthalmol-2020-317337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639936/
https://www.ncbi.nlm.nih.gov/pubmed/33055088
http://dx.doi.org/10.1136/bjophthalmol-2020-317337

Ejemplares similares